Westby Keith's Form 4 filing
IVERIC bio, Inc. (ISEE) · filed May 3, 2023
- Accession no.
- 0001410939-23-000061
- Filed
- May 3, 2023
- Trade date
- May 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Westby KeithCIK 0001696429 | Officer (SVP, Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | Common Stock | MOption exerciseAcquired | +8,786 | $4.52 | +$39,712.72 | 48,438 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −8,786 | $37.12F2 | −$326,136.32 | 39,652 | Direct | |
| May 1, 2023 | Common Stock | MOption exerciseAcquired | +11,214 | $5.22 | +$58,537.08 | 50,866 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −11,214 | $37.12F2 | −$416,263.68 | 39,652 | Direct | |
| May 2, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $2.94 | +$58,800 | 59,652 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −20,000 | $37.81F3 | −$756,200 | 39,652 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | Common Stock | MOption exerciseDisposed | −8,786 | $4.52 | −$39,712.72 | 0 | Direct | |
| May 1, 2023 | Common Stock | MOption exerciseDisposed | −11,214 | $5.22 | −$58,537.08 | 63,786 | Direct | |
| May 2, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $2.94 | −$58,800 | 120,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $36.79 to $37.50 per share on May 1, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
Referenced by the price of 2 transactions in Table I.
- F3
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $37.63 to $38.04 per share on May 2, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.